Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Synbio Tech's Enterprise Value is NT$2,444.6 Mil.
Synbio Tech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$153.7 Mil. Therefore, Synbio Tech's EV-to-EBIT ratio for today is 15.91.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Synbio Tech's Enterprise Value is NT$2,444.6 Mil.
Synbio Tech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$230.5 Mil. Therefore, Synbio Tech's EV-to-EBITDA ratio for today is 10.60.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Synbio Tech's Enterprise Value is NT$2,444.6 Mil.
Synbio Tech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$823.3 Mil. Therefore, Synbio Tech's EV-to-Revenue ratio for today is 2.97.
Synbio Tech Enterprise Value Historical Data
The historical data trend for Synbio Tech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Synbio Tech's Enterprise Value
For the Biotechnology subindustry, Synbio Tech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Enterprise Value falls into.
Synbio Tech Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Synbio Tech's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Synbio Tech's current Enterprise Value is NT$2,444.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Synbio Tech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$153.7 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Synbio Tech's current Enterprise Value is NT$2,444.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Synbio Tech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$230.5 Mil.
Synbio Tech's current Enterprise Value is NT$2,444.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Synbio Tech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$823.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech Enterprise Value Related Terms
Thank you for viewing the detailed overview of Synbio Tech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Synbio Tech Inc is a company specializing in the research, manufacturing and application development of lactic acid bacteria. They provide lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products , share application development technology, provide excellent service quality, and gain recognition from customers, allowing Shenghe to grow steadily.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:1295 has been successfully added to your